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ment of valid and reliable measures for compliance
behavior is still needed.
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OBJECTIVE: This study: 1) investigates the relationship
between Self-efﬁcacy (SE) (conﬁdence in competent in a
speciﬁc situation) and compliance with medical regimens
in three groups of patients namely: Chronic maintenance
care for diabetes—a life-threatening illness; Similar 
care for hypertension—a non-life threatening disease, and
Acute care with antibiotics for infection—an episodic 
disorder with or without life-threatening potential; 2)
explores SE for different levels of compliance (with 3 
diseases) in self-administration of prescribed drugs; 3)
identiﬁes other variables relating to compliance in the
respondents at Adisorn Fort, Saraburi Province, Thailand
2001. METHOD: A descriptive cross-sectional survey
was employed to study relationships between SE and
compliance. The response rate was 100% (n = 180). De
Geese’s SE Scale had alpha .8680 and Sorofman’s 
Compliance scale with 2 constructs (correct amount and
correct time) had alpha .8280 and .9459. RESULTS:
Research conﬁrmed that the stronger a patient’s Self-
efﬁcacy, the more reliably he/she complied to regimens 
for self-administration of maintenance and acute-care
medication. SE selectively predicted adherence in 3 dis-
tinct categories of drug therapy: Diabetes > Hypertension
> Antibiotics and compliance in Diabetes > Hypertension
> Antibiotics as well (p < .05). Statistical signiﬁcance for
predicting compliance was found in SE model (R2.695).
Male had more SE and comply than female (p < .05).
There were inverse correlation between education and SE
and negatively correlation between SE and compliance as
well (R-.199,-.189). The length of time for patients got
disease correlated to SE and compliance (R.475, .508) (p
< .05). The elderly had the more SE and more compliance
to medical regimens than the younger (R .415, .404).
Social support inﬂuenced SE and compliance. Patients
with spouses had more SE and more comply with medical
regimens than patients who lived alone (p < .05). CON-
CLUSION: SE played an important role in predicting
compliance. SE was selective among diseases.
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OBJECTIVE: Compliance with chronic medications 
is poor, resulting in lost clinical beneﬁts and wasted
resources. Developing evidence-based compliance pro-
grams is difﬁcult because the literature is often equivocal,
contradictory, or of poor methodological quality. The
objectives of this study were: 1) to assess the relationship
between methodological rigor in program evaluation and
probability of intervention success; and 2) to identify 
the characteristics of compliance interventions that most
strongly predict positive outcomes. METHODS: We
searched the MEDLINE database for controlled studies
of interventions designed to improve patient compliance
with prescription medications for asthma, dyslipidemia,
hypertension, depression, and diabetes (English-only,
published between 1982 and 2002). Each study was
abstracted for methodological rigor and intervention
design. Compliance programs were considered “success-
ful” if the authors demonstrated a statistically signiﬁcant
improvement in compliance compared to a control group.
RESULTS: Sixty-four controlled studies were identiﬁed,
in which 76 compliance interventions were evaluated.
Overall, 68% of the interventions improved compliance.
Of 20 interventions evaluated based on self-reported
compliance, 9 (45%) were successful; 41 of 54 interven-
tions (76%) that measured compliance via pill count,
electronic monitoring, or pharmacy records were suc-
cessful (p = 0.02). There were nine broad categories 
of intervention types, the most frequent of which were
improved dosing convenience (n = 20 interventions, 
70% successful), intensive clinician management (n = 7,
57% successful), counseling (n = 7, 57% successful), and
reminders (n = 6, 66% successful). In addition, 20 of 
25 programs (80%) consisting of multiple interventions
were successful. CONCLUSION: Reliance on self-
reported medication use appears to bias results against
the intervention. This may be because patients report
exaggerated levels of compliance in both intervention 
and control groups, creating a “ceiling effect” that
reduces the observable difference. Common attributes of
successful programs included simpliﬁed treatment 
regimens, facilitation of provider-patient relationships,
and multi-faceted patient education methods. Combina-
tion interventions had higher rates of success than indi-
vidual tactics.
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OBJECTIVES: We deﬁne “compliance” as the “the extent
of correspondence between the patient’s dosing history
and the prescribed dosing regimen”, and “persistence” as
the time between the ﬁrst- and last-taken doses. They are
related in that persistence increases one dose at a time.
